Medscape

New data for MannKind’s Afrezza will be used in a supplemental new drug application for a pediatric indication. Medscape Medical News

Corticosteroids had no effect on mortality rates or serious adverse events in patients with HIV and tuberculosis, showed a recent meta-analy...

Family history of mental illness is linked to aggression, especially in midlife, in individuals with chronic traumatic encephalopathy, new r...

Combination of anti-CD19 and CD20 monoclonal antibodies could represent “new standard of care” in follicular lymphoma. Medscape Medical N...

The details of hidradenitis suppurativa pathophysiology are being recharacterized, placing more emphasis on early diagnosis and aggressive t...

Participants using cannabis for mental health reasons demonstrated higher depression scores at each trimester. Medscape Medical News

Eltrombopag shows improved platelet counts and quality-of-life outcomes in treating pediatric immune thrombocytopenia. Medscape Medical N...

A new algorithm eliminates a second rescreen if a newborn falls into the retest category, allowing for earlier intervention, and changes the...

Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with GLP-1 RAs cutting the risk by 33%, new resear...

Covering a shift over Christmas and New Year’s may not be everyone’s first choice, but there are rewards. Medscape Medical News

Final results in phase 3 Andromeda trial confirmed daratumumab regimen as standard of care for newly diagnosed AL amyloidosis. Medscape M...

The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with stages II-III...

New data show significant state and regional variations in long COVID rates, and experts think they know why. Medscape Medical News

A group of 15 experts showed wide ranging definitions, prompting a call for guidelines. Medscape Medical News

From uncovering treatments at speeds once thought impossible to diagnosing diseases with pinpoint accuracy, AI is rewriting the rules of med...

At 2 years, results from the COMET trial suggest surveillance is safe, but longer follow-up is needed. Medscape Medical News

The population most affected by HIV has changed in recent years, and public health messaging may not be reaching the appropriate audience....

The strain causing most of the infections among people experiencing homelessness in Vancouver, Canada, is multidrug-resistant, new research...

Early surgical intervention was superior to an endoscopy-first approach in patients with painful chronic pancreatitis, a study of long-term...

From 2015 to 2022 the rate of antibiotic dispensation for UTIs climbed by 227.3% per 1000 patients, outpacing the 159.8% increase in positiv...

A new study found that both new and follow-up patients, when examined, are evaluated efficiently, although many are not examined at all....

Participants in a trial were randomized to receive either 200 mg camrelizumab or placebo combined with chemotherapy every 2 weeks for 14 mon...

Alert-based monitoring of patient-reported symptoms significantly improves fatigue and quality of life and prolongs survival in advanced bre...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was approximately 80 consecutiv...

Public health initiatives and physical education policies could incorporate ways to support movement among gender-diverse youth. Medscape...